Código QR

Evaluation of ongoing mepolizumab treatment in chronic rhinosinusitis with nasal polyps

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifactorial inflammatory disease of the mucous membranes of the nose and paranasal sinuses. Eosinophilic inflammation is described as a common endotype. The anti-interleukin-5 (IL-5) antibody mepolizumab was approved in November 2021 as an ad...

ver descrição completa

Na minha lista:
Principais autores: Ludger Klimek, Ulrike Förster-Ruhrmann, Heidi Olze, Achim G. Beule, Adam M. Chaker, Jan Hagemann, Tilmann Huppertz, Thomas K. Hoffmann, Stefan Dazert, Thomas Deitmer, Sebastian Strieth, Holger Wrede, Wolfgang Schlenter, Hans-Jürgen Welkoborsky, Barbara Wollenberg, Sven Becker, Frederike Bärhold, Felix Klimek, Ingrid Casper, Jaron Zuberbier, Claudia Rudack, Mandy Cuevas, Constantin A. Hintschich, Orlando Guntinas-Lichius, Timo Stöver, Christoph Bergmann, Pascal Werminghaus, Oliver Pfaar, Jan Gosepath, Moritz Gröger, Caroline Beutner, Martin Laudien, Rainer K. Weber, Tanja Hildenbrand, Anna-Sophie Hoffmann, Claus Bachert
Formato: Artigo
Idioma:Inglês
Publicado em: Open Exploration Publishing Inc. 2024-02-01
Colecção:Exploration of Asthma & Allergy
Assuntos:
chronic rhinosinusitis
chronic rhinosinusitis with nasal polyps
biologics
eosinophilic inflammation
mepolizumab
Acesso em linha:https://www.explorationpub.com/uploads/Article/A100927/100927.pdf
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados